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Abstract
Genotype data from the Illumina Linkage III SNP panel (n = 4,720 SNPs) and the Affymetrix 10 k
mapping array (n = 11,120 SNPs) were used to test the effects of linkage disequilibrium (LD)
between SNPs in a linkage analysis in the Collaborative Study on the Genetics of Alcoholism
pedigree collection (143 pedigrees; 1,614 individuals). The average r2 between adjacent markers
across the genetic map was 0.099 ± 0.003 in the Illumina III panel and 0.17 ± 0.003 in the Affymetrix
10 k array. In order to determine the effect of LD between marker loci in a nonparametric
multipoint linkage analysis, markers in strong LD with another marker (r2 > 0.40) were removed (n
= 471 loci in the Illumina panel; n = 1,804 loci in the Affymetrix panel) and the linkage analysis
results were compared to the results using the entire marker sets. In all analyses using the ALDX1
phenotype, 8 linkage regions on 5 chromosomes (2, 7, 10, 11, X) were detected (peak markers p
< 0.01), and the Illumina panel detected an additional region on chromosome 6. Analysis of the
same pedigree set and ALDX1 phenotype using short tandem repeat markers (STRs) resulted in 3
linkage regions on 3 chromosomes (peak markers p < 0.01). These results suggest that in this
pedigree set, LD between loci with spacing similar to the SNP panels tested may not significantly
affect the overall detection of linkage regions in a genome scan. Moreover, since the data quality
and information content are greatly improved in the SNP panels over STR genotyping methods,
new linkage regions may be identified due to higher information content and data quality in a dense
SNP linkage panel.
Background
For many years short tandem repeat (STR) or microsatel-
lite markers have been used as the standard genetic mark-
ers for linkage mapping [1-5]. STRs typically have a high
degree of heterozygosity and provide high information
content per marker [6]. They occur widely throughout the
genome, with over 5,000 STRs being mapped to a high-
resolution genetic map [5]. However, a drawback to using
microsatellite markers is that because of the large number
of alleles differing by as few as 2 to 4 bp, analysis has
required electrophoretic separation. Because of this tech-
nical limitation, their analysis is time consuming and not
amenable to highly multiplexed, automated formats.
In contrast, single-nucleotide polymorphism (SNP)
assays are more amenable to multiplexing and are easier
to automate, which increases accuracy and reliability.
Therefore, more complete linkage studies with thousands
of markers, and studies with large numbers of DNA sam-
ples are more feasible using SNPs. In addition, there is an
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abundance of SNPs: currently over 8 million human SNPs
are in public databases, many of which have been vali-
dated http://www.ncbi.nlm.nih.gov/SNP/. Recent reports
have shown SNP linkage panels have higher information
content and data quality than STR marker panels [7-9].
However, an important consideration for using numerous
closely spaced SNPs in a linkage analysis is the analytical
method used for statistical analysis of the genotype data.
Genotyping many SNPs at high density compensates for
the fact that each individual SNP has limited heterozygos-
ity (maximum theoretical heterozygosity = 50%). There-
fore, in order to maximize the information content (IC),
one must use multipoint linkage analysis across a map of
densely spaced SNPs or use multi-SNP haplotypes in a
two-point linkage analysis. Another important considera-
tion is the amount of linkage disequilibrium (LD) that
exists between loci when using a mapping panel of
densely spaced SNPs in a linkage analysis. Existing linkage
analysis programs assume linkage equilibrium between
loci. This assumption is violated if LD exists between SNP
loci and may introduce a bias in the resulting LOD score.
This report describes the results of determining the
amount of LD that exists between loci in two different
high-density SNP linkage panels and their effect on the
overall linkage analysis results using 143 Collaborative
Study on the Genetics of Alcoholism (COGA) pedigrees
segregating the ALDX1 phenotype.
Methods
Samples
One hundred forty-three pedigrees from the COGA study
comprised 1,614 individuals (1,332 genotyped individu-
als) segregating alcoholism were used in all analyses. The
143 pedigrees had 256 sibships. Of these 256 sibships,
123 (48%) had both parents, 75 (29%) had 1 parent, and
58 (23%) had no parents available for SNP genotyping.
The majority of the individuals had a self-reported ethnic-
ity of White, non-Hispanic (n = 1,074). The next largest
self-reported ethnic group was black, non-Hispanic (n =
191).
Genetic markers
The Illumina Linkage III SNP panel and the Affymetrix 10
k mapping array were used for both LD calculations and
linkage analyses. The Illumina panel used for the Genetic
Analysis Workshop 14 study had 4,720 SNP loci with a
mean and median physical spacing of 615 kb and 406 kb,
respectively. The data were of exceptional quality with a
high call rate (99.95%), low error rate (0.005%), and low
rate of Mendelian inconsistencies (0.09%). From a genetic
map generated from 28 CEPH pedigrees [9], the mean and
median genetic spacing was 1.5 cM and 1.1 cM, respec-
tively. The Affymetrix 10 k mapping array had 11,120 loci
with a mean and median physical spacing of 210 kb and
105 kb, respectively. The data were also of high quality
with a 94.75% call rate, 0.052% error rate, and 0.12% rate
of Mendelian inconsistencies. From a genetic map derived
from linear interpolation of physical map position and a
high resolution microsatellite genetic map, the mean
genetic spacing was 0.32 cM [8]. The COGA STR marker
set had 328 markers with an average genetic spacing of
10.45 cM. Previously the data quality for the COGA STR
dataset were reported [10], and the missing genotype rate
and Mendelian inconsistency rate were grouped together
and estimated to be 4%. The error rate was estimated to be
0.8%.
Evaluation of inter-marker LD
Inter-marker LD was determined from between all SNP
loci in the two SNP panels, respectively, in 244 unrelated
individuals. LD strength was derived from estimated hap-
lotypes using the expectation-maximization algorithm of
Slatkin and Excoffier [11] as implemented in the ldmax
component of the program GOLD [12]. LD strength, as
measured by the parameter r2, was determined for each
pair-wise combination. In particular, LD between each
adjacent marker on the genetic map used for linkage anal-
ysis was investigated. Loci in strong LD with another
marker (r2 > 0.40) were removed and the linkage analysis
was repeated using the subset of markers where all loci
have no or weak LD (r2 < 0.40).
Multipoint nonparametric linkage (NPL) analysis
Linkage analysis of both SNP panels and the COGA STR
panel were analyzed using the ALDX1 phenotype. Geno-
type data were analyzed using multipoint nonparametric
methods as implemented in GENEHUNTER v2.1 [13] on
all pedigrees using the map distances provided with the
genotype data. For the SNP loci, because the markers are
densely mapped, multipoint analyses were carried out
using one step between each marker. For the STR loci,
multipoint analyses were carried out using four steps
between each marker. Peak loci were determined as those
regions with p-values < 0.01.
Results
Inter-marker LD
LD strength (r2) between each adjacent marker pair on the
genetic map was evaluated in both SNP panels. For the
Illumina SNP panel, the average r2 between each adjacent
marker pair on the genetic map was 0.099 ± 0.003 (SD =
0.23). As shown in Figure 1a, >75% of all marker pairs
had an r2 < 0.05. Figure 1b shows the proportion of
marker pairs that have r2 > 0.4 by chromosome. The X
chromosome had the highest proportion of marker pairs
with r2 > 0.4 (33/123 marker pairs; 27%). Overall, 471/
4,697 marker pairs (10%) had r2 > 0.4. One marker from
each of the 471 marker pairs with r2 > 0.40 was randomly
removed. In the case where there were multiple adjacent
SNPs with r2 > 0.40, the minimum numbers of loci wereBMC Genetics 2005, 6:S85
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removed so that the remaining adjacent loci had r2 < 0.40.
LD strength in the Illumina Linkage III SNP panel (ILMN) and the Affymetrix 10 k mapping array (AFFY) Figure 1
LD strength in the Illumina Linkage III SNP panel (ILMN) and the Affymetrix 10 k mapping array (AFFY). a) 
Distribution of marker pairs by LD strength (r2); b) Proportion of marker pairs r2 > 0.4 by chromosome (chromosome 23 = X 
chromosome).
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Multipoint NPL analysis of ALDX1 phenotype using the Illumina III SNP linkage panel Figure 2
Multipoint NPL analysis of ALDX1 phenotype using the Illumina III SNP linkage panel. Multipoint NPL scores 
across the entire chromosome for all SNPs (blue line) and a subset of SNPs with weak or no LD (orange line) are shown for 
the six chromosomes that have regions with corresponding p-values < 0.01. In addition, the information content (IC) curves 
are also shown for all loci (green line) and the subset of SNPs with weak or no LD (pink line).
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A subset of 4,149 loci was used for subsequent linkage
analyses where all loci had weak or no LD. For the Affyme-
trix SNP panel, the average LD between loci was higher (as
expected) because the SNPs are more closely spaced. The
average  r2  between each adjacent marker pair on the
genetic map was 0.17 ± 0.003 (SD = 0.30), and less than
65% of all marker pairs had an r2 < 0.05 (Figure 1a). There
were 1,804 marker pairs with r2 > 0.40. One marker from
each pair was removed for subsequent linkage analysis
using the remaining 9,316 loci with weak or no LD.
NPL multipoint analysis
Genotype data were analyzed using the ALDX1 phenotype
and the NPL multipoint analysis methods as imple-
mented in the program GENEHUNTER v2.1 [12]. For the
complete set of 4,720 SNP loci in the Illumina SNP panel,
nine regions on six chromosomes (chromosomes 2, 6, 7,
10, 11, X) had peak NPL scores with corresponding p-val-
ues < 0.01 and are summarized in Table 1. Next, a subset
of the Illumina SNP panel was analyzed where all 4,149
loci had weak or no LD (r2 < 0.40). The same nine regions
on six chromosomes were identified in this analysis.
These results are also shown in Table 1. The biggest differ-
ence in results between the two analyses (all loci versus
loci with no or weak LD) occurred on the X chromosome,
where a high proportion of loci (17%) were removed and
the IC at the linkage peak dropped from 0.93 to 0.88. The
linkage peak shifted approximately 5 cM between the two
analyses. Another big difference between the two analyses
occurred on chromosome 6, where 3 of the 9 loci in the
interval were removed, including the peak marker from
the analysis of all loci. The analysis using a subset of mark-
ers was still significant (p = 0.004), though less significant
than the analysis with all loci (p = 0.0006). Even though
there were moderate differences between the two analyses
on these two chromosomes, the same regions were iden-
tified in both analyses with p-values ≤ 0.01. The six chro-
mosomes with p-values ≤ 0.01 are shown in Figure 2. For
the complete set of 11,120 loci in the Affymetrix 10 k
Mapping Array, eight regions on five chromosomes (chro-
mosomes 2, 7, 10, 11, X) had peak NPL scores with corre-
sponding p-values < 0.01 as shown in Table 1. A second
analysis without the 1,804 loci in strong LD resulted in
the same eight regions and similar NPL scores and p-val-
ues (Table 1). The Affymetrix SNP panel did detect a peak
at the same region on chromosome 6 as in the Illumina
SNP panel, however the p-value was > 0.01 (Table 1, Fig-
ure 3). The five chromosomes with linkage regions (p <
0.01) are shown in Figure 3.
IC was also compared across all marker sets as shown in
Table 2. The genome-wide average IC for the Illumina set
was 0.89 (min = 0.33, max = 0.97) with only one chromo-
some having an average IC < 0.80. In addition, the IC was
consistently high across most of the genome (with the
exception of a gap in Xq23-q28), with 2 chromosomes
having a minimum IC less than 0.70. The genome-wide
average IC of the Affymetrix set was slightly higher (aver-
age IC = 0.90, range = 0.43–0.97) with all chromosomes
having an average IC > 0.80. Even though this panel had
Table 1: Linkage results using the Illumina Linkage III SNP Panel and the Affymetrix 10 k Mapping Array.
Illumina III SNP linkage panel Affymetrix 10 k mapping array
Chr Marker Position 
(cM)
Build34 bp NPL p-value IC Marker Position 
(cM)
Build34 bp NPL p-value IC
2p25 rs1025053 16.1 8238143 2.53 0.0073 0.89 tsc0041232 5.74 2888794 2.71 0.0047 0.91
2p25 rs1025053 16.1 8238143 2.64 0.0056 0.90 tsc0041232 5.74 2888794 2.43 0.0095 0.91
2p14 rs1000756 89.9 66769368 3.31 0.00090 0.93 tsc1090282 90.58 67905612 3.82 0.00019 0.94
2p14 rs1106577 89.9 67023129 3.26 0.0010 0.93 tsc1090282 90.58 67905612 3.80 0.00021 0.94
2q37 rs1453867 239.2 233120438 2.39 0.010 0.93 tsc0524987 244.44 236010878 2.71 0.0046 0.89
2q37 rs1453867 239.2 233120438 2.38 0.010 0.93 tsc0524987 244.44 236010878 2.68 0.0051 0.89
6q27 rs760909 188.1 170713389 3.46 0.00058 0.86 tsc0050465 185.42 multiple pos. 1.85 0.035 0.81
6q27 rs727619 188.1 170562703 2.79 0.0037 0.88 tsc0050465 185.42 multiple pos. 1.77 0.041 0.81
7p22-21 rs1057558 0 806704 2.62 0.0058 0.89 tsc1592599 31.68 17610703 2.55 0.0070 0.94
7p22-21 rs1127460 0 623105 2.35 0.011 0.89 tsc0925001 31.35 17305065 2.42 0.0096 0.93
7q21 rs1023564 101.1 88453743 2.54 0.0071 0.94 tsc0049271 101.05 89624115 2.77 0.0039 0.94
7q21 rs717474 101.1 88403326 2.54 0.0072 0.94 tsc1240889 99.05 85964828 2.82 0.0035 0.94
10q26 rs1536087 159.6 131394560 2.90 0.0028 0.90 tsc0960887 171.41 132054567 3.25 0.0011 0.88
10q26 rs1536087 159.6 131394560 2.92 0.0027 0.90 tsc0960887 171.41 132054567 3.03 0.0020 0.87
11q23 rs617847 126.1 120940295 2.65 0.0054 0.90 tsc0053512 125.27 121196164 2.82 0.0035 0.92
11q23 rs575030 125.1 120630050 2.57 0.0066 0.91 tsc0051264 125.15 121112747 2.51 0.0076 0.92
Xp22 rs225031 39.7 28452585 2.34 0.011 0.93 tsc0038428 42.78 25961925 2.55 0.0071 0.97
Xp22 rs795489 34.4 23062119 2.89 0.0030 0.88 tsc0038428 42.78 25961925 2.68 0.0053 0.94
aPeak loci p < 0.01 for all loci (bold) and loci r2 < 0.40 (not bold)1BMC Genetics 2005, 6:S85
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over twice the number of loci, there were only modest
improvements in average IC, and actually there were more
regions of lower IC, since 8 chromosomes had a mini-
mum IC < 0.70.
Finally, STR data were analyzed using the ALDX1 pheno-
type. Two of the 9 linkage peaks detected using the high-
density SNP map were detected with STRs at p < 0.01. The
resulting peak loci and linkage intervals are summarized
in Table 3. The peak on chromosome 7 does not overlap
with the two peaks on chromosome 7 detected using high
density SNPs, however it is flanked by the two peaks
detected in the SNP panels. As shown in Table 2, the
genome-wide IC was considerably lower than both SNP
panels (average = 0.61), since no chromosomes had an
average IC > 0.80. In addition, all chromosomes had min-
imum IC < 0.70.
Discussion
An early study suggested that if LD exists between a trait
and marker and if LD is not taken into account in a link-
age analysis, the resulting LOD score would be reduced
[14]. However, LD that exists between two marker loci
may not necessarily have the same bias, and could in fact
artificially increase a LOD score in a linkage analysis. For
example, if haplotype frequencies are calculated assuming
linkage equilibrium when in fact LD exists and the linked
haplotype frequency is underestimated, then this could
artificially inflate the resulting LOD score [15]. This effect
would be largest in pedigrees in which genotypes are not
available for founding individuals. In this study using the
Illumina SNP panel, a low level of LD was detected
between each SNP overall, and 78% of all marker pairs in
order of the genetic map had an r2 < 0.05. Using the
Affymetrix mapping array, a higher proportion of marker
pairs had high LD genome-wide, and 65% of all marker
pairs had an r2 < 0.05.
Overall, in both SNP panels there was very little difference
between results using the entire marker set and the
reduced marker set without loci in strong LD. Using both
SNP panels, the same regions were detected in both anal-
yses at p < 0.01, with modest changes in p-values and NPL
scores. The NPL scores and p-values did not consistently
become more or less significant with the removal of loci
in LD. In addition, there was high concordance in terms
of significance and location of linkage peaks between the
two SNP mapping panels. The main difference in findings
between the two panels was that the Affymetrix mapping
array did not detect the linkage peak at p < 0.01 on chro-
Multipoint NPL analysis of ALDX1 phenotype using the Affymetrix 10 k Mapping Array Figure 3
Multipoint NPL analysis of ALDX1 phenotype using the Affymetrix 10 k Mapping Array. Multipoint NPL scores 
across the entire chromosome for all SNPs (blue line) and a subset of SNPs with weak or no LD (orange line) are shown for 
six chromosomes. Chromosomes 2, 7, 10, 11, and X have regions with corresponding p-values < 0.01; chromosome 6 is 
shown for comparison with the Illumina SNP mapping panel results. In addition, the information content (IC) curves are also 
shown for all loci (green line) and the subset of SNPs with weak or no LD (pink line).
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mosome 6. This result could have occurred for many rea-
sons. The IC is lower in this region (IC = 0.81 at peak
marker). In addition, because the peak marker does not
map uniquely in the build 34 genome assembly, the
genetic map position may not be accurate since the
genetic map position is linked to physical map position
through linear interpolation in this SNP panel. Finally,
this result could be a false-positive result in the Illumina
mapping panel.
The analysis of STR markers in the same pedigree set
resulted in only 3 linkage peaks with corresponding p-val-
ues < 0.01. Two of these regions (2p14, 11q23) over-
lapped with the SNP linkage results and the third region
(7p14) did not overlap although it was between two of
the SNP linkage peaks (7p22, 7q21). In addition, the IC
using the STR data was approximately 3–21% lower at the
linkage peaks compared with the high density SNP data.
Conclusion
The results on this study suggest that LD between loci in a
linkage analysis does not significantly affect the overall
detection of linkage regions in a genome scan. However,
this result is dependent on the number of genotyped
founders or unaffected siblings in the pedigrees because
the potential bias in LOD score due to underlying LD
Table 3: Linkage results using the COGA STR marker set (regions with peak p-values < 0.01)
Chromosome Marker Position (cM) Build34 bp NPL LOD p-value IC
2p14 D2S285 94.2 67620904 2.56 1.42 0.0070 0.90
7p14 D7S2846 56.8 37875515 2.67 1.55 0.0052 0.86
11q23 D11S1998 119.8 117235383 2.61 1.47 0.0062 0.69
Table 2: Information content comparisons in the two SNP marker sets and the COGA STR marker set (Average (min, max))
Chromosome Illumina Affymetrix COGA STR (all loci)
all loci r2 < 0.4 all loci r2 < 0.4
1 0.91 (0.75,0.95) 0.91 (0.75,0.96) 0.91 (0.69,0.95) 0.91 (0.69,0.95) 0.64 (0.28,0.90)
2 0.91 (0.79,0.95) 0.91 (0.79,0.95) 0.92 (0.78,0.96) 0.92 (0.77,0.96) 0.70 (0.47,0.90)
3 0.91 (0.82,0.95) 0.91 (0.83,0.95) 0.92 (0.84,0.97) 0.92 (0.83,0.97) 0.59 (0.41,0.86)
4 0.89 (0.72,0.96) 0.89 (0.72,0.95) 0.91 (0.59,0.96) 0.91 (0.59,0.96) 0.62 (0.47,0.78)
5 0.90 (0.77,0.95) 0.90 (0.77,0.95) 0.92 (0.75,0.96) 0.92 (0.75,0.96) 0.63 (0.37,0.85)
6 0.90 (0.72,0.96) 0.90 (0.71,0.95) 0.92 (0.71,0.96) 0.92 (0.71,0.96) 0.60 (0.37,0.84)
7 0.91 (0.78,0.95) 0.91 (0.78,0.95) 0.91 (0.78,0.96) 0.91 (0.77,0.95) 0.78 (0.59,0.92)
8 0.90 (0.79,0.95) 0.89 (0.75,0.95) 0.91 (0.75,0.95) 0.91 (0.75,0.95) 0.67 (0.44,0.87)
9 0.89 (0.78,0.95) 0.89 (0.77,0.95) 0.91 (0.70,0.96) 0.91 (0.69,0.96) 0.62 (0.47,0.85)
10 0.89 (0.78,0.95) 0.89 (0.78,0.95) 0.91 (0.68,0.95) 0.91 (0.68,0.95) 0.48 (0.31,0.76)
11 0.89 (0.66,0.95) 0.89 (0.66,0.95) 0.92 (0.70,0.96) 0.92 (0.69,0.96) 0.51 (0.30,0.74)
12 0.90 (0.75,0.95) 0.89 (0.75,0.95) 0.90 (0.74,0.96) 0.90 (0.74,0.96) 0.65 (0.38,0.90)
13 0.90 (0.77,0.95) 0.89 (0.76,0.95) 0.91 (0.62,0.96) 0.91 (0.62,0.96) 0.62 (0.33,0.86)
14 0.90 (0.79,0.95) 0.89 (0.79,0.95) 0.86 (0.43,0.95) 0.86 (0.42,0.95) 0.62 (0.49,0.79)
15 0.89 (0.77,0.95) 0.89 (0.76,0.95) 0.90 (0.83,0.95) 0.90 (0.83,0.95) 0.67 (0.56,0.85)
16 0.90 (0.75,0.95) 0.89 (0.74,0.95) 0.87 (0.46,0.95) 0.86 (0.46,0.95) 0.57 (0.33,0.82)
17 0.89 (0.79,0.94) 0.88 (0.78,0.94) 0.85 (0.51,0.94) 0.85 (0.51,0.94) 0.56 (0.35,0.77)
18 0.88 (0.75,0.95) 0.88 (0.75,0.95) 0.91 (0.70,0.95) 0.91 (0.70,0.95) 0.51 (0.35,0.69)
19 0.88 (0.73,0.95) 0.86 (0.71,0.94) 0.81 (0.57,0.94) 0.81 (0.56,0.94) 0.56 (0.41,0.76)
20 0.89 (0.82,0.94) 0.89 (0.80,0.94) 0.89 (0.78,0.95) 0.89 (0.71,0.95) 0.60 (0.39,0.82)
21 0.91 (0.85,0.94) 0.90 (0.84,0.94) 0.92 (0.75,0.95) 0.91 (0.75,0.95) 0.59 (0.39,0.83)
22 0.89 (0.79,0.95) 0.88 (0.78,0.95) 0.84 (0.77,0.94) 0.84 (0.77,0.94) 0.55 (0.34,0.76)
X 0.74 (0.33,0.97) 0.72 (0.20,0.97) 0.91 (0.84,0.97) 0.88 (0.78,0.95) 0.32 (0.24,0.40)
Genome 0.89 (0.33,0.97) 0.89 (0.20,0.96) 0.90 (0.43,0.97) 0.90 (0.42,0.97) 0.61 (0.24,0.92)
No. chr w/avg IC < 0.8 1 1 0 0 23
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between SNP loci in a linkage analysis is largest in pedi-
grees in which genotypes are not available for founding
individuals. Therefore, one strategy to determine the effect
that LD has on a linkage analysis in other pedigree collec-
tions might be to re-run a linkage analysis using a subset
of loci with weak or no LD in the pedigree collection being
studied. Therefore, one can determine if a linkage result is
being inflated by underlying LD between SNP loci in the
linkage peak. Despite the potential bias of a resulting LOD
score, the high-density SNP panels provide an order of
magnitude higher data quality compared to STR genotyp-
ing methods and also provide higher IC. In this study, sev-
eral new linkage regions may have been identified that
were not detected using a 10-cM STR marker panel due to
higher IC and data quality in the dense SNP linkage pan-
els.
Abbreviations
COGA: Collaborative Study of the Genetic of Acoholism
IC: Information Content
LD: Linkage disequilibrium
NPL: Nonparametric linkage
STR: Short tandem repeat marker
SNP: Single-nucleotide polymorphism
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